Accueil > Les Laboratoires > CHU de Rennes > Publications de l’équipe

Les Laboratoires

Années 2017-2020


>In vitro activity of eravacycline and mechanisms of resistance in enterococci. Boukthir S, Dejoies L, Zouari A, Collet A, Potrel S, Auger G, Cattoir V. Int J Antimicrob Agents. 2020 Oct 26:106215.

>Streptogramins for the treatment of infections caused by Gram-positive pathogens. Reissier S, Cattoir V. Expert Rev Anti Infect Ther. 2020 Oct 26:1-13.

>Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage. Fluckiger A, Daillère R, Sassi M, Sixt BS, Liu P, Loos F, Richard C, Rabu C, Alou MT, Goubet AG, Lemaitre F, Ferrere G, Derosa L, Duong CPM, Messaoudene M, Gagné A, Joubert P, De Sordi L, Debarbieux L, Simon S, Scarlata CM, Ayyoub M, Palermo B, Facciolo F, Boidot R, Wheeler R, Boneca IG, Sztupinszki Z, Papp K, Csabai I, Pasolli E, Segata N, Lopez-Otin C, Szallasi Z, Andre F, Iebba V, Quiniou V, Klatzmann D, Boukhalil J, Khelaifia S, Raoult D, Albiges L, Escudier B, Eggermont A, Mami-Chouaib F, Nistico P, Ghiringhelli F, Routy B, Labarrière N, Cattoir V, Kroemer G, Zitvogel L.Science. 2020 Aug 21369(6506):936-942.

>ResFinder 4.0 for predictions of phenotypes from genotypes. Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, Philippon A, Allesoe RL, Rebelo AR, Florensa AF, Fagelhauer L, Chakraborty T, Neumann B, Werner G, Bender JK, Stingl K, Nguyen M, Coppens J, Xavier BB, Malhotra-Kumar S, Westh H, Pinholt M, Anjum MF, Duggett NA, Kempf I, Nykäsenoja S, Olkkola S, Wieczorek K, Amaro A, Clemente L, Mossong J, Losch S, Ragimbeau C, Lund O, Aarestrup FM.J Antimicrob Chemother. 2020 Aug 11:dkaa345.

>Unexpected Cell Wall Alteration-Mediated Bactericidal Activity of the Antifungal Caspofungin against Vancomycin-Resistant Enterococcus faecium. Isnard C, Hernandez SB, Guérin F, Joalland F, Goux D, Gravey F, Auzou M, Enot D, Meignen P, Giard JC, Cava F, Cattoir V.Antimicrob Agents Chemother. 2020 Sep 2164(10):e01261-20.

>Molecular basis of macrolide-lincosamide-streptogramin (MLS) resistance in Finegoldia magna clinical isolates. Guérin F, Lachaal S, Auzou M, Le Brun C, Barraud O, Decousser JW, Lienhard R, Baraduc R, Dubreuil L, Cattoir V.Anaerobe. 2020 Aug64:102220.

>Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis. Dejoies L, Boukthir S, Péan de Ponfilly G, Le Guen R, Zouari A, Potrel S, Collet A, Auger G, Jacquier H, Fihman V, Dortet L, Cattoir V.J Antimicrob Chemother. 2020 Sep 175(9):2587-2593.

>Molecular and functional analysis of the novel cfr(D) linezolid resistance gene identified in Enterococcus faecium. Guerin F, Sassi M, Dejoies L, Zouari A, Schutz S, Potrel S, Auzou M, Collet A, Lecointe D, Auger G, Cattoir V.J Antimicrob Chemother. 2020 Jul 175(7):1699-1703.

>Paradoxical High-Level Spiramycin Resistance and Erythromycin Susceptibility due to 23S rRNA Mutation in Streptococcus constellatus. Capitaine A, Woerther PL, Auzou M, Chachaty E, Guérin F, Giard JC, Cattoir V, Isnard C.Microb Drug Resist. 2020 Jul26(7):727-731.

>Helcococcus kunzii methyltransferase Erm(47) responsible for MLSB resistance is induced by diverse ribosome-targeting antibiotics. Guerin F, Rose S, Cattoir V, Douthwaite S.J Antimicrob Chemother. 2020 Feb 175(2):371-378.

>In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates. Peiffer-Smadja N, Guillotel E, Luque-Paz D, Maataoui N, Lescure FX, Cattoir V.J Antimicrob Chemother. 2019 Dec 174(12):3511-3514.

>A novel genomic island harbouring lsa(E) and lnu(B) genes and a defective prophage in a Streptococcus pyogenes isolate resistant to lincosamide, streptogramin A and pleuromutilin antibiotics. Berbel D, Càmara J, García E, Tubau F, Guérin F, Giard JC, Domínguez MÁ, Cattoir V, Ardanuy C.Int J Antimicrob Agents. 2019 Nov54(5):647-651.

>Unexpected Activity of Oral Fosfomycin against Resistant Strains of Escherichia coli in Murine Pyelonephritis. Pourbaix A, Guérin F, Burdet C, Massias L, Chau F, Cattoir V, Fantin B.Antimicrob Agents Chemother. 2019 Jul 2563(8):e00903-19.

>Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16. Sassi M, Guérin F, Zouari A, Beyrouthy R, Auzou M, Fines-Guyon M, Potrel S, Dejoies L, Collet A, Boukthir S, Auger G, Bonnet R, Cattoir V.J Antimicrob Chemother. 2019 Jun 174(6):1469-1472.

>Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States. Mendes RE, Jones RN, Woosley LN, Cattoir V, Castanheira M.Open Forum Infect Dis. 2019 Mar 156(Suppl 1):S69-S78.

>Future Antibacterial Strategies: From Basic Concepts to Clinical Challenges. Cattoir V, Felden B.J Infect Dis. 2019 Jul 2220(3):350-360.

>In vitro antimicrobial susceptibility of equine clinical isolates from France, 2006-2016. Duchesne R, Castagnet S, Maillard K, Petry S, Cattoir V, Giard JC, Leon A.J Glob Antimicrob Resist. 2019 Dec19:144-153.

>Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature. Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM, Westh H, Hammerum AM, Schaffer K, Burns K, Murchan S, Novais C, Freitas AR, Peixe L, Del Grosso M, Pantosti A, Werner G.Drug Resist Updat. 2018 Sep40:25-39.

>Bacterial Adaptation to Antibiotics through Regulatory RNAs. Felden B, Cattoir V.Antimicrob Agents Chemother. 2018 Apr 2662(5):e02503-17.

>Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium. Lebreton F, Valentino MD, Schaufler K, Earl AM, Cattoir V, Gilmore MS.J Antimicrob Chemother. 2018 Jun 173(6):1479-1486.

>In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections. Isnard C, Dhalluin A, Malandain D, Bruey Q, Auzou M, Michon J, Giard JC, Guérin F, Cattoir V.J Glob Antimicrob Resist. 2018 Jun13:221-225.

>Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate. Sassi M, Guérin F, Lesec L, Isnard C, Fines-Guyon M, Cattoir V, Giard JC.J Antimicrob Chemother. 2018 Apr 173(4):852-855.

>In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis. Reissier S, Saleh-Mghir A, Guerin F, Massias L, Ghout I, Sinel C, Cattoir V, Cremieux AC.J Antimicrob Chemother. 2018 Apr 173(4):981-986.

>In vitro activity of tedizolid and comparator agents against Gram-positive pathogens responsible for bone and joint infections. Ract P, Piau-Couapel C, Compain F, Auzou M, Michon J, Cattoir V.J Med Microbiol. 2017 Oct66(10):1374-1378.

>Small RNAs in vancomycin-resistant Enterococcus faecium involved in daptomycin response and resistance. Sinel C, Augagneur Y, Sassi M, Bronsard J, Cacaci M, Guérin F, Sanguinetti M, Meignen P, Cattoir V, Felden B.Sci Rep. 2017 Sep 117(1):11067.

>Nationwide molecular epidemiology of methicillin-resistant Staphylococcus aureus responsible for horse infections in France. Guérin F, Fines-Guyon M, Meignen P, Delente G, Fondrinier C, Bourdon N, Cattoir V, Léon A.BMC Microbiol. 2017 May 317(1):104.

>Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers. De Lastours V, Maugy E, Mathy V, Chau F, Rossi B, Guérin F, Cattoir V, Fantin B CIPHARES Study Group.J Antimicrob Chemother. 2017 Jun 1.

>Subinhibitory Concentrations of Ciprofloxacin Enhance Antimicrobial Resistance and Pathogenicity of Enterococcus faecium. Sinel C, Cacaci M, Meignen P, Guérin F, Davies BW, Sanguinetti M, Giard JC, Cattoir V.Antimicrob Agents Chemother. 2017 Apr 2461(5):e02763-16.